FDA approves second drug for a site-agnostic indication; larotrectinib was tested across 17 cancer types

“This is our time, and the time is now”—Chapman tells us about Jefferson’s final push for Comprehensive designation

Sidney Kimmel Cancer Center at Jefferson Health can add the word “Comprehensive” to its name, becoming the 57 institution to earn this top-level designation from NCI. xxx:more

April 19, 2024

Vol.50 No.16

By Paul Goldberg

Guest Editorial

Leading a Comprehensive Cancer Center—one job or two?

Comprehensive cancer centers seek to reduce the burden of cancer through clinical care, research, education, and community engagement, including a commitment to diversity.

Call to action: To address Black cancer disparities, focus on research prioritization and clinical studies inclusion
Minority Cancer Awareness Week

People of African ancestry (Black/African American) have some of the worst cancer incidence and greatest mortality, compared to white and other racial and ethnic populations in the U.S. On average, Black persons are 1.5 times more likely to have cancer and >2X more likely to die from cancer compared to whites. xxx:more

April 19, 2024

Vol.50 No.16

By Kimlin Tam Ashing, Nadine J. Barrett, Kim F. Rhoads, Folakemi T. Odedina, Hayley S. Thompson and Camille C. R. Ragin

Cancer History Project

Surviving lung cancer focused Morhaf Al Achkar’s career on addressing health disparities

Something felt wrong during one of Morhaf Al Achkar’s regular runs on the treadmill in late 2016. He started gasping for breath.

April 19, 2024

Vol.50 No.16

By McKenzie Prillaman

In the Archives

Tobacco in the tabloids: How the Weekly World News covered smoking for laughs—and the National Enquirer wouldn’t cover it at all

In a new online exhibition, The University of Alabama Center for the Study of Tobacco and Society examines tobacco in the tabloids.

April 19, 2024

Vol.50 No.16

In Brief

Andrew Smith named chair of St. Jude Diagnostic Imaging Department

Andrew Smith was named chair of St. Jude’s Diagnostic Imaging Department. He succeeds Beth McCarville, who was interim chair of the department since the death of Zoltan Patay, who held the position from 2017 to 2022.

April 19, 2024

Vol.50 No.16

FDA approves second drug for a site-agnostic indication;

larotrectinib was tested across 17 cancer types

YOU MAY BE INTERESTED IN

“This is our time, and the time is now”—Chapman tells us about Jefferson’s final push for Comprehensive designation

Leading a Comprehensive Cancer Center—one job or two?

Call to action: To address Black cancer disparities, focus on research prioritization and clinical studies inclusion
Minority Cancer Awareness Week

Surviving lung cancer focused Morhaf Al Achkar’s career on addressing health disparities

Tobacco in the tabloids: How the Weekly World News covered smoking for laughs—and the National Enquirer wouldn’t cover it at all

Andrew Smith named chair of St. Jude Diagnostic Imaging Department

Renew today!

Subscriber content

Login

FDA approves second drug for a site-agnostic indication;

larotrectinib was tested across 17 cancer types

YOU MAY BE INTERESTED IN

“This is our time, and the time is now”—Chapman tells us about Jefferson’s final push for Comprehensive designation

Leading a Comprehensive Cancer Center—one job or two?

Call to action: To address Black cancer disparities, focus on research prioritization and clinical studies inclusionMinority Cancer Awareness Week

Surviving lung cancer focused Morhaf Al Achkar’s career on addressing health disparities

Tobacco in the tabloids: How the Weekly World News covered smoking for laughs—and the National Enquirer wouldn’t cover it at all

Andrew Smith named chair of St. Jude Diagnostic Imaging Department

Login

Call to action: To address Black cancer disparities, focus on research prioritization and clinical studies inclusion
Minority Cancer Awareness Week